"Given the controversy and implications, it is reasonable for the government (in this case the NIH and FDA) to take a bit of time to review both the positive and negative studies before release, though this is understandably very frustrating for patients. Unfortunately, the NIH and CDC have generated enormous (and I suspect often well deserved) mistrust in the CFS/FMS community. The question is whether the study review will be fair and honest, or if the data will be buried to protect insurance company profits. Unfortunately, since they have now quickly released the "XMRV negative" study for publication and are still holding back the "XMRV positive" study, ****it is again leaving many with CFS feeling like the government is ready to throw them under the bus again.**** It would have made more sense to have waited until the review was complete and then release both studies simultaneously."

"Given the controversy and implications, it is reasonable for the government (in this case the NIH and FDA) to take a bit of time to review both the positive and negative studies before release, though this is understandably very frustrating for patients. Unfortunately, the NIH and CDC have generated enormous (and I suspect often well deserved) mistrust in the CFS/FMS community. The question is whether the study review will be fair and honest, or if the data will be buried to protect insurance company profits. Unfortunately, since they have now quickly released the "XMRV negative" study for publication and are still holding back the "XMRV positive" study, ****it is again leaving many with CFS feeling like the government is ready to throw them under the bus again.**** It would have made more sense to have waited until the review was complete and then release both studies simultaneously."